BTI Regenera
Liquide, membrane, eye drops

Persistent epithelial defects

BTI Sleep
Liquide, membrane, eye drops

Anterior segment surgery

BTI Academy
Liquide, membrane

Posterior segment surgery

BTI Publishing
Formulación del producto

BTI Publishing

Editorial especializada en publicaciones científicas y técnicas del sector biomédico.

BTI Studio
Formulación del producto

BTI Studio

Centro de diseño y desarrollo de soluciones innovadoras para el sector de la biomedicina.

BTI Farma
Formulación del producto

BTI Farma

Soluciones farmacéuticas avanzadas de BTI para el sector de la biomedicina y la implantología.

BTI Item 8
Formulación del producto

BTI Item 8

Descripción del octavo elemento del slider de marcas BTI.

Etiqueta

BTI Item 9

Descripción del noveno elemento del slider de marcas BTI.

Etiqueta

BTI Item 10

Descripción del décimo elemento del slider de marcas BTI.

Advantages of PRGF - ENDORET® in ophthalmology

Ventajas del sistema CORE-X
  • Acceleration of tissue regeneration

    Highly effective in the treatment of Persistent Epithelial Defects (PEDs) of diverse aetiologies, including neurogenic, iatrogenic and burn-related causes, achieving complete healing in 85% of patients in a mean of 10.9 weeks, in cases where mean progression with other conventional treatments was 26.7 weeks.

  • Efficacy following previous treatment failure

    Successfully restores corneal epithelial integrity even in patients in whom previous treatment with conventional autologous serum had not been effective.

  • Anti-inflammatory effect

    Directly reduces inflammation in ocular tissue, minimising the need for chronic adjunctive therapies such as corticosteroids and ciclosporin.

  • Anti-fibrotic capacity

    Its high antifibrotic potential supports corneal transparency and actively protects against the development of corneal scarring and leucomas.

  • Use as a culture medium

    Use as a culture medium for stem cell expansion (for example, limbal cells)

  • Texto de ejemplo

    Texto de ejemplo

Eye Drop Kit (Home Use)


Enables a complete course of treatment lasting up to 6 months.


Safe long-term storage by freezing at -20°C.


Each individual single-dose device/dispenser remains stable for up to 72 hours at room temperature, facilitating daily use anywhere without the need for constant refrigeration.


Rapid and straightforward preparation procedure, entirely free from dilution steps.


Editorial científica

Surgical Kit (Surgical Setting)


Through a single standardised protocol, the specialist can obtain up to 4 different formulations, including liquid plasma and clot, for use as a graft or injectable.


Allows preparation of an autologous fibrin membrane distinguished by being suturable, resistant, easy to handle and completely resorbable by the body.


Editorial científica

Frequently asked questions

How does autologous serum differ from the eye drops produced with PRGF - ENDORET® technology?

Yes. Whereas other generic PRP eye drops may present variable platelet concentrations and non-standardised processing, PRGF - ENDORET® technology is based on strictly defined and validated protocols. This guarantees an optimal concentration of platelets and growth factors, directly influencing the final efficacy of treatment. In addition, its preparation method ensures a formulation completely free of leucocytes, removing components that promote pain, inflammation or fibrin degradation, thereby offering a high level of safety and clinical reproducibility.

What are the properties of the fibrin membrane obtained with PRGF - ENDORET® technology in ocular surgery?

The ocular surgery kit based on PRGF - ENDORET® technology allows a 100% autologous fibrin membrane to be prepared during the same surgical procedure, using the patient’s own blood. As a purely endogenous product, it offers absolute biocompatibility, with no risk of immunological rejection or reported adverse reactions. In the surgical setting, this three-dimensional matrix is distinguished by its mechanical resistance, suturability, ease of handling for the specialist and complete resorbability by the body, acting as an ideal scaffold that regulates the progressive release of proteins in order to accelerate the natural regeneration of ocular tissue.

What is the difference between the membrane produced with PRGF-ENDORET® technology and the amniotic membrane?

The amniotic membrane is an allogeneic tissue (obtained from an external donor) which, although effective, involves a complex preservation process and a minimal latent risk of pathogen transmission or immunological rejection. By contrast, the fibrin membrane produced with PRGF-ENDORET® technology is 100% autologous (from the patient), is moulded to the exact required dimensions during the surgical procedure itself, and offers absolute biocompatibility, accelerating natural regeneration without any risk of rejection.

¿Qué diferencias existen entre los distintos tipos de implantes disponibles?

Texto de ejemplo

¿Qué complicaciones pueden surgir después de la colocación de un implante y cómo se previenen?

Texto de ejemplo

Texto de ejemplo

Texto de ejemplo

Texto de ejemplo

Texto de ejemplo

Texto de ejemplo

Texto de ejemplo

Texto de ejemplo

Texto de ejemplo

Texto de ejemplo

Texto de ejemplo

Contact us

Close-up
Nombre

Apellidos

Email

¿Cómo quieres que contactemos contigo? *

Teléfono

Código postal

País

Escribe aquí tu consulta *